U.S. General Merchandise and Department Stores Stock News

Valero Energy (VLO) attracted fresh attention after its second quarter 2026 results showed a large improvement in adjusted earnings per share and revenues, along with a top Zacks Rank based on expected earnings growth. Against this backdrop, Valero Energy’s share price has climbed to $346.59, supported by a 30 day share price return of 15.96% and a 90 day share price return of 41.57%. The 1 year total shareholder return of 134.15% shows how strong the recent momentum has been despite a small...

Workday (NasdaqGS: WDAY) and Salary.com announced a certified integration that automates compensation data management for joint customers. The integration connects Workday Human Capital Management with Salary.com to synchronize job, employee, and pay data for compensation teams. Customers gain a direct link between internal compensation management and external market pricing data to support pay decisions. Early adoption from financial services firms highlights immediate interest from sectors...

Chemed stock performance snapshot after recent price moves Chemed (CHE) has drawn fresh attention after recent price moves, with the stock last closing at US$520.27. That level reflects mixed short term returns and a stronger picture over the past 3 months. Over the past year Chemed has delivered a 15.74% total shareholder return. The recent 1 day share price move down 5.16% to US$520.27 contrasts with a 22.01% 90 day share price return, suggesting momentum has cooled slightly after a strong...

Recently, Celsius Holdings reported weaker-than-expected second-quarter earnings, prompting several brokerages including Deutsche Bank, Bernstein, and Maxim to downgrade the energy drink maker due to concerns over softer core brand trends and a longer recovery timeline into fiscal 2027. This clash between cautious analyst revisions and earlier optimism about Celsius’ growth and profitability potential highlights how sensitive the company’s valuation is to shifts in earnings...

Shopify stock has delivered a strong 3 year return, yet several valuation checks now suggest the shares trade at a premium to what the company’s current cash flow profile and fundamentals may justify. Both a Discounted Cash Flow (DCF) intrinsic value estimate and market multiple comparisons point in the same direction, which puts the recent share price strength under the spotlight for investors. Over the past 3 years, Shopify has returned about 132.1% which puts extra focus on whether...

Franklin Templeton recently paid a quarterly cash dividend of US$0.33 per share on October 9, 2026, to shareholders of record on September 30, 2026, matching the prior quarter’s payout and reflecting a 3.1% increase over the same quarter a year earlier. Separately, HashKey Holdings Limited announced a collaboration under which HashKey Exchange will distribute Franklin Templeton’s tokenized Franklin OnChain U.S. Government Liquidity Fund (grBENJI) to eligible digital asset investors in Asia,...

Vulcan Materials has delivered a solid 55.7% total return over the past 5 years, yet current valuation checks suggest the stock is trading at a premium to its estimated intrinsic value. Both cash flow based and market multiple assessments currently point to Vulcan Materials looking expensive rather than like an obvious bargain. The 55.7% gain over 5 years indicates that long-term holders have already captured a significant portion of the value on offer from Vulcan Materials. Future pricing...

Earlier in August, Steel Dynamics’ board declared a third-quarter cash dividend of US$0.53 per share, payable on or about October 9, 2026, to shareholders of record as of September 30, 2026. This dividend affirmation comes alongside analyst expectations for stronger earnings and potential benefits from proposed U.S. tariffs on Canadian steel and vehicles, which together highlight how policy and payout decisions may influence the company’s outlook. Now we’ll examine how the proposed 50%...

Recent Share Price Moves and What They Mean for Camden Property Trust Camden Property Trust (CPT) has drawn attention after its share price closed at US$105.79, with returns down about 2% over the past week and 8% over the past month. Investors are weighing these moves against the company’s recent financial trends. Looking beyond the recent pullback, Camden Property Trust’s share price return has slipped over the past month, while the year to date move is more modest and the one year total...

FirstEnergy earnings beat puts Energize365 investments in focus FirstEnergy (FE) recently reported second quarter 2026 adjusted earnings of $0.50 per share, topping estimates and drawing investor attention to how its capital plan and transmission projects might shape the stock. The company also reaffirmed its 2026 core earnings guidance and confirmed plans to invest $6b under its Energize365 program. That update, together with progress on new generation and solar projects, gives investors...

In recent days, Cognex Corporation has seen analysts raise their earnings estimates for upcoming quarters and the full year, reflecting stronger expectations for its financial performance. This wave of upward revisions has also improved its ranking in third-party rating systems that focus on earnings estimate trends, highlighting a shift in sentiment among covering analysts. Next, we’ll examine how these upward earnings estimate revisions may influence Cognex’s existing investment narrative...

Hims & Hers Health (HIMS) is back in focus after regulators accused the telehealth company of deceptive subscription practices and improper sharing of sensitive health data. This has prompted fresh questions around legal risk and customer trust. Against this regulatory backdrop, Hims & Hers Health’s share price has been volatile, with a 1-day share price return of 6.13% but a year-to-date share price return that is down 5.24%. The 3-year total shareholder return of about 3.7x indicates that...

Quanta Services (PWR) drew fresh attention after the Quanta Services tokenized stock on Robinhood reached its all time high on 27 August 2026, highlighting renewed interest in exposure to the underlying shares. Over the past year, momentum in Quanta Services has been strong, with the share price at $621.83 and a year-to-date share price return of 41.43%. The 1-year total shareholder return of 61.25% and 5-year total shareholder return of 449.60% point to a stock where long-term holders have...

AES stock has delivered a weak overall result over the past five years, yet several valuation checks now suggest the current share price may sit below what its cash flows imply. The question for investors is whether AES is a genuine value opportunity or simply reflecting the challenges embedded in its recent track record. The share price is down about 26.4% over the last five years, which points to a period where long term holders have not been rewarded. Expectations for future cash...

Why the ALKIVIA results matter for Zai Lab stock Zai Lab (ZLAB) stock action is currently anchored to fresh clinical data from the ALKIVIA Phase 3 trial of VYVGART Hytrulo in autoimmune myositis, which met its primary endpoint with statistically significant results. The study showed a 15.4 point greater improvement in Total Improvement Score at Week 52 versus placebo in the combined immune mediated necrotizing myopathy and dermatomyositis population, with benefits emerging by Week 4 and...

AXT stock has delivered an extremely strong run over the past few years, yet the latest valuation checks suggest the shares now lean expensive rather than offering clear value. After such a sharp move, investors are weighing the recent gains against what the broader valuation signals and fundamentals imply for risk and reward. Over the past 3 years, AXT has returned about 24x, which puts a spotlight on how much future growth is already reflected in the share price. Expectations that higher...

Acadia Pharmaceuticals has received European Commission marketing authorization for DAYBU (trofinetide) to treat neurobehavioral symptoms of Rett syndrome in patients aged five and older across the European Union, Iceland, Liechtenstein, and Norway, based on Phase 3 LAVENDER data showing statistically significant and clinically meaningful improvements on key clinical scales. This approval makes DAYBU the first and only authorized therapy for Rett syndrome in the EU, potentially opening a new...

Guidewire Software recently reported earnings for the quarter ended July 2026, delivering year-over-year growth in both earnings and revenue after earlier caution from analysts. The negative Earnings ESP ahead of the release highlighted growing analyst uncertainty, making the subsequent earnings call a focal point for understanding business conditions and expectations. With mixed analyst sentiment highlighted by the negative Earnings ESP, we’ll now examine how this earnings setup shapes...

Plug Power stock has delivered a very weak long term result, with the share price down about 91.6% over the past 5 years. However, current valuation checks still point to an expensive profile rather than a clear bargain. Recent price gains and ongoing news around project cancellations and funding challenges keep attention on whether the current market value matches the company’s risk and return trade off. Over 5 years, Plug Power shares have fallen about 91.6%, which signals that long term...

Why Owens Corning stock is back on investors’ radar Owens Corning (OC) has drawn fresh attention after brokerage research pointed to an average recommendation that sits between Strong Buy and Buy, supported by higher earnings estimates and a Zacks Rank #2 rating. The share price of Owens Corning closed at US$143.68, with short term momentum softening after a 1-day share price return that declined 1.39% and a 7-day share price return that declined 2.36%, even as the 90-day share price return...

Incyte recently reported past second-quarter 2026 results that exceeded earnings and revenue expectations, supported by strong demand for Jakafi and Opzelura, and raised its 2026 net product revenue guidance. The FDA’s approval of Niktimvo for chronic graft-versus-host disease adds another commercial therapy to Incyte’s portfolio, potentially broadening its revenue base beyond Jakafi. Next, we’ll explore how the raised 2026 revenue guidance, underpinned by Opzelura demand, reshapes Incyte’s...

Cigna Group (CI) just announced a connected benefits solution for employees on high-deductible health plans, linking medical and supplemental coverage to simplify claims and speed up access to cash benefits after covered health events. Cigna Group’s connected benefits launch comes as the stock consolidates after a mixed stretch, with the share price down about 7.8% over the past month but roughly flat over 90 days. Total shareholder return of about 39.5% over five years points to steadier...

Dollar General (NYSE: DG) reported a strong second quarter with significant growth in net income and same store sales. The company raised its full year earnings guidance following the quarterly results. Dollar General announced a new AI driven supply chain partnership with RELEX Solutions to support forecasting, replenishment, and allocation. For a wider view on how AI driven operations are shaping opportunities beyond Dollar General, explore the companies grouped in 55 AI infrastructure...

With no single headline event driving attention, interest in Upbound Group (UPBD) today centers on how the stock’s recent performance and valuation metrics compare with its current profitability and revenue profile. At a share price of $19.29, Upbound Group has seen short term momentum soften, with the 30 day share price return down 10.65% after a 7 day share price gain of 4.05%. The 1 year total shareholder return is down 19.12% and the 5 year total shareholder return is down 60.06%,...